33
Participants
Start Date
June 10, 2014
Primary Completion Date
June 27, 2017
Study Completion Date
Fidaxomicin
Metronidazole
Vancomycin
Duke University Medical Center, Durham
Lead Sponsor
Duke University
OTHER